title: Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.
abstract: Many individuals with hepatitis C virus (HCV) infection are undiagnosed. This study evaluates a risk assessment questionnaire, developed for use online to target blood-screening for HCV. Two hundred and eighty-nine patients with known HCV status completed a written questionnaire on prominent HCV risk factors. Questionnaires generated advice to seek testing if at least one risk factor was reported. Agreement of the testing advice with the HCV status of respondents was evaluated. Subsequently, we validated our questionnaire among 985 patients of an outpatient clinic for sexually transmitted infections. The post-test-probability-of-disease (PTPD) and diagnostic gain (PTPD minus prior probability of disease) were calculated. The questionnaire's sensitivity and specificity were 84.6% and 63.8%, respectively, and higher in the STI clinic patients. The PTPD of positive testing advice was 72.5% given HCV prevalence of 53.0%, yielding a diagnostic gain of 19.5%. Applying the estimated prevalence in the general Dutch population (0.1-0.4%), and the anticipated prevalence in the online project (1.0-6.0%), yielded diagnostic gains of 0.13-0.53% and 1.3-7.0%, respectively. We conclude that our questionnaire succeeded in selecting at-risk individuals as its testing advice agreed well with the HCV status. We suggest that the questionnaire be used online as a selection tool for HCV blood-screening in the general population.
authors.affiliation: Cluster Infectious Diseases, Department of Research, Amsterdam Public Health Service, Amsterdam, the Netherlands. fzuure@ggd.amsterdam.nl
authors.forename: F
authors.initials: F
authors.lastname: Zuure
authors.forename: U
authors.initials: U
authors.lastname: Davidovich
authors.forename: G
authors.initials: G
authors.lastname: Kok
authors.forename: A C
authors.initials: AC
authors.lastname: Depla
authors.forename: C
authors.initials: C
authors.lastname: Hoebe
authors.forename: A
authors.initials: A
authors.lastname: van den Hoek
authors.forename: P L
authors.initials: PL
authors.lastname: Jansen
authors.forename: P
authors.initials: P
authors.lastname: van Leeuwen-Gilbert
authors.forename: C J
authors.initials: CJ
authors.lastname: Weegink
authors.forename: R A
authors.initials: RA
authors.lastname: Coutinho
authors.forename: M
authors.initials: M
authors.lastname: Prins
mesh_terms: D000328:Adult; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D018570:Risk Assessment / Q000379:methods*; D012680:Sensitivity and Specificity; D011795:Surveys and Questionnaires